Drug Topics
AUGUST 28, 2023
A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.
PharmaVoice
AUGUST 28, 2023
As Novo Nordisk’s drug Wegovy sways Denmark’s economy, we're examining wider implications for the weight loss market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 28, 2023
A recent study found that there was a lack of strong evidence supporting the use of continuous glucose monitor programs in community pharmacies.
PharmaVoice
AUGUST 28, 2023
In the high-growth but competitive field of migraine treatments, CGRP drugs have changed the game — but the search is still on for more options.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
AUGUST 28, 2023
Researchers believe a recent study shows how living in neighborhoods with high and very high levels of opportunity in early life is associated with lower asthma incidence in childhood.
Pharmacy Times
AUGUST 28, 2023
Advanced technology can automate many pharmacovigilance tasks to build workflow efficiencies, reduce manual intervention, and free up team members for more strategic activities.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 28, 2023
Although the patient demographics are similar for the 3 categories of hemolytic reactions with intravenous immunoglobulin, the reaction with delayed hemolytic transfusion reactions was highest compared to the other 2 hemolytic reactions.
Fierce Healthcare
AUGUST 28, 2023
Earlier this year, HCA Healthcare launched a pilot program that equipped 75 emergency room physicians at four hospitals with Google’s AI technology, utilizing an ongoing partnership with Google Clo | HCA Healthcare wants to spread generative AI tools beyond four hospitals in an initial pilot program, as well as incorporate Google's medical LLM.
Pharmacy Times
AUGUST 28, 2023
With the help of new and complex algorithms and self-learning models, we are currently privy to what we may look back on as the golden era of AI.
Fierce Healthcare
AUGUST 28, 2023
Rite Aid is reportedly preparing to file for bankruptcy within a few weeks to help restructure its debt and potentially halt ongoing lawsuits. | The bankruptcy would reportedly pause the many legal claims against the retailer and allow it to consolidate and resolve them in one place.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 28, 2023
Pharmacists' expertise is invaluable to prescribers who are unfamiliar with opioid use disorder treatment protocols.
European Pharmaceutical Review
AUGUST 28, 2023
Novartis has announced that Leqvio ® (inclisiran) , the first and only small interfering RNA (siRNA) therapy indicated to reduce low-density lipoprotein cholesterol (LDL-C), has demonstrated promising long-term results. This is based on three-year follow up data from a Phase III trial, presented at the European Society of Cardiology (ESC) Congress 2023.
Pharmacy Times
AUGUST 28, 2023
KET01 could successfully treat treatment-resistant depression while limiting adverse effects in the home environment, according to the study.
STAT
AUGUST 28, 2023
The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be. The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 28, 2023
The start date of the package-level electronic tracking system will shift from November 27, 2023 to November 27, 2024.
Drug Store News
AUGUST 28, 2023
Rite Aid is reportedly planning to file for bankruptcy to address federal and state lawsuits it is facing over its alleged role in the sale of opioids, per a WSJ report.
Pharmacy Times
AUGUST 28, 2023
Perhaps the most significant development in the pharmaceutical industry in decades, crops of biosimilars are being approved and are ready for distribution. What lies next, in terms of legislation and the impact on pharmacists, remains to be seen.
Fierce Healthcare
AUGUST 28, 2023
L.A. Care Health Plan is investing $4.05 million in a street medicine initiative to expand access to care for unsheltered people. | Nine organizations offering street medicine services will each receive up to $500,000 from the health plan. The program aims to beef up street medicine teams serving LA, as well as to ensure people without stable housing do not drop off Medi-Cal amid Medicaid redeterminations.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 28, 2023
When you’re a psychiatrist, there’s no such thing as a typical day. But if you’re working in a clinic setting (like one of us, Jessi, is currently, and the other, Simone, has done previously), one thing is for sure: You’re busy. And it’s not just about seeing patients — it’s the seemingly ever-increasing electronic messages.
Fierce Healthcare
AUGUST 28, 2023
Bon Secours Mercy Health took its ongoing spat with regional Elevance Health plans to the next level on Monday, filing suit against the insurer alleging that it owed more than $93 million in unpaid | Bon Secours Mercy Health took its ongoing spat with regional Elevance Health plans to the next level on Monday, filing suit against the insurer alleging that it owed more than $93 million in unpaid claims.
Pharmaceutical Technology
AUGUST 28, 2023
Specialised Therapeutics has entered into a licensing agreement with Treeway for TW001, designed for treating amyotrophic lateral sclerosis.
STAT
AUGUST 28, 2023
Long Island is in the midst of a housing crisis. Just like in many other parts of the country, Long Islanders are having a tough time finding affordable housing — an issue that is intimately connected with health. Earlier this year, New York Gov. Kathy Hochul put forth a plan to deal with the housing challenges. Her ambitious goal: to construct 800,000 new homes and apartment units throughout the state over the next decade.
Fierce Healthcare
AUGUST 28, 2023
As health plans drop costly GLP-1 drugs, controversially leaving people without access to potentially life-changing therapies, health companies are hoping to fill the marketplace void to provide be | Obesity impacts roughly 40% of Americans, but insurers are becoming less willing to cover weight loss drugs for the disease. Health companies are looking to bridge the gap.
pharmaphorum
AUGUST 28, 2023
Could #MedThreads become the new #MedTwitter? Mike.
STAT
AUGUST 28, 2023
In response to growing complaints, the U.S. Food and Drug Administration has postponed its plans to enforce a law designed to thwart counterfeit or diverted medicines passing through the pharmaceutical supply chain. The law was supposed to be fully enforced in late November, but the agency now says it will not take action until November 2024. At issue is the Drug Supply Chain Security Act, which has been implemented in steps over the past decade.
Fierce Healthcare
AUGUST 28, 2023
Blue Cross Blue Shield of Massachusetts announced< | Blue Cross Blue Shield of Massachusetts tapped Paul Long to serve as the health plan’s chief consumer experience officer.
STAT
AUGUST 28, 2023
Striking moderators of the infectious diseases surveillance website ProMED have been given an ultimatum: Signal their interest in remaining with the program by Wednesday and return to work on Friday, or they will be considered to have “moved on” from the organization. The moderators, subject matter experts who are paid a nominal stipend for curating and contextualizing the numerous infectious diseases reports ProMED posts to its website and pumps out to its mailing list daily, have
Drug Store News
AUGUST 28, 2023
Kroger's scholarship program has granted more than $4.8 million in scholarship funds.
Fierce Healthcare
AUGUST 28, 2023
Nationwide hospital finances hit a rough patch in July as reduced patient volumes, a bump in bad debt and charity care whittled operating margins. | Patient volumes, particularly in outpatient settings, saw a steep month-over-month decline while Medicaid redetermination appears to have sparked a bump in bad debt and charity care, per Kaufman Hall.
Fierce Pharma
AUGUST 28, 2023
It’s a sale. Two months after Abcam launched a strategic review of the company, the British antibody research expert has revealed that it’s being bought by Danaher. | Danaher Corporation is picking up all outstanding shares of Abcam for $24 apiece. Both companies’ boards unanimously approved the decision, Danaher and Abcam said Monday. The deal is expected to close in mid-2024.
Drug Store News
AUGUST 28, 2023
From Aug. 28 through Sept. 10, Welch’s Fruit Snacks is inviting teachers nationwide to participate in the program.
Fierce Pharma
AUGUST 28, 2023
With seven posters and nine presentations on Farxiga over the weekend at the European Society of Cardiology (ESC) scientific sessions in Amsterdam, AstraZeneca made it clear that it has lots to say | As AstraZeneca's Farxiga has added four indications over the last five years—on top of its initial 2014 approval for Type 2 diabetes—its spillover benefits have become apparent and yielded a better understanding of the interconnections between Type 2 diabetes, heart failure and chronic kidney d
OctariusRx
AUGUST 28, 2023
The 2023 version of the OctariusRx medication safety quiz is about to be released. Ongoing education and assessments of staff medication management competency are standards of good practice. Medication competency and your consultant pharmacist are two things that should go hand-in-hand. How are you assessing your staff? Use our tool to help enhance patient safety and satisfy the regulatory requirement.
Expert insights. Personalized for you.
469 
Let's personalize your content